SynthesisBMC cancer2024

Discontinuation risk from adverse events: immunotherapy alone vs. combined with chemotherapy: a systematic review and network meta-analysis.

Sangwon Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.